KRRO (Korro Bio) Buyback Yield %: -44.73 (As of Jul. 03, 2026)


KRRO Korro Bio Inc KRRO
6 GF Score
Price $14.05
! 5 Warning Signs
View Full Analysis

What is Korro Bio Buyback Yield %?

Korro Bio KRRO +2.41% 6 Buyback Yield % is -44.73 as of Jul. 03, 2026. GuruFocus rates KRRO with a GF Score™ of 6/100. The stock has 5 warning signs investors should review. Among 745 Biotechnology companies, Korro Bio ranks worse than 82.15% on this metric.

Buyback yield is the net repurchase of shares outstanding over the market capital of the company. It is a measure of shareholder return.

Korro Bio's current buyback yield was -44.73%.

Korro Bio Buyback Yield % Historical Data

* Premium members only.

The historical data trend for Korro Bio's Buyback Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Korro Bio Buyback Yield % Chart

Korro Bio Annual Data
Trend Dec21 Dec22 Dec23 Dec24 Dec25
Buyback Yield %
0.00 0.00 -30.51 -18.88 0.00

Korro Bio Quarterly Data
Dec21 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Buyback Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 -54.02

KRRO vs LENZ, ANTX, OKUR: Buyback Yield % Comparison

For the Biotechnology subindustry, Korro Bio's Buyback Yield %, along with its competitors' market caps and Buyback Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Korro Bio Buyback Yield % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Korro Bio's Buyback Yield % distribution charts can be found below:

* The bar in red indicates where Korro Bio's Buyback Yield % falls into.


KRRO
6GF Score
Korro Bio Inc KRRO
Buyback Yield % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Korro Bio Buyback Yield % Calculation

Buyback yield is a measure of shareholder return.

Korro Bio's Buyback Yield for the fiscal year that ended in Dec. 2025 is calculated as

Buyback Yield=Net Issuance of Stock / Market Cap
=- (Repurchase of Stock + Issuance of Stock) / Market Cap
=- (0 + 0) / 75.43017
=0.00%

Korro Bio's annualized Buyback Yield for the quarter that ended in Mar. 2026 is calculated as

Buyback Yield=Net Issuance of Stock(TTM) / Market Cap
=- (Repurchase of Stock + Issuance of Stock) (TTM)** / Market Cap
=- (0 + 88.195) / 163.26836
=-54.02%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** If the quarter corresponds to the year-end period, we will use the annual Repurchase of Stock and Issuance of Stock data .

Frequently Asked Questions Learn more about Buyback Yield % →
What does a Buyback Yield % of -44.73 mean?
Korro Bio (KRRO) has a Buyback Yield % of -44.73 as of Jul. 03, 2026. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on Korro Bio and its competitors. According to the industry distribution chart, Korro Bio ranks #612 out of 745 companies in the Biotechnology industry, placing it in the top 82.1%.
Is Korro Bio's Buyback Yield % too high?
Korro Bio's current Buyback Yield % is -44.73. Based on the distribution chart, Korro Bio ranks #612 out of 745 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Korro Bio has a GF Score™ of 6/100, reflecting its overall financial health beyond just this single metric.
How does Korro Bio's Buyback Yield % compare to LENZ and ANTX?
According to the Biotechnology industry distribution chart, Korro Bio ranks #612 out of 745 companies for Buyback Yield %. This places Korro Bio in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Buyback Yield % for a Biotechnology company?
A good Buyback Yield % depends on the Biotechnology industry context. However, Buyback Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Buyback Yield % mean?
A high Buyback Yield % can signal that a stock is expensive relative to its fundamentals. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on Korro Bio and its competitors. Korro Bio's current Buyback Yield % is -44.73. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Korro Bio stock overvalued right now?
Korro Bio (KRRO) has a current Buyback Yield % of -44.73. The current Buyback Yield % is -44.73. Korro Bio's overall GF Score™ is 6/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Buyback Yield % calculated?
Buyback Yield % is calculated from a company's financial statements. For Korro Bio (KRRO), the current Buyback Yield % is -44.73 as of Jul. 03, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Korro Bio Business Description

Address 60 First Street, 2nd Floor, Suite 250, Cambridge, MA, USA, 02141
Korro Bio Inc is a biopharmaceutical company with a mission to discover, develop, and commercialize a new class of genetic medicines based on editing RNA, enabling the treatment of both rare and highly prevalent diseases. It is generating a portfolio of differentiated programs that are designed to harness the body's natural RNA editing process to effect a precise yet transient single base edit. By editing RNA instead of DNA, Korro Bio is expanding the reach of genetic medicines by delivering additional precision and tunability. The company operates and manages its business as one reportable segment and one operating segment, which is the business of discovering, developing and commercializing therapies derived from or incorporating its RNA-editing technology.
6GF Score

Get the complete analysis for KRRO

Buyback Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$14.05
Price